z-logo
Premium
Venous thromboembolism prophylaxis audit in two Q ueensland hospitals
Author(s) -
Phillips N. M.,
Heazlewood V. J.
Publication year - 2013
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12033
Subject(s) - medicine , warfarin , venous thromboembolism , observational study , adverse effect , pulmonary embolism , retrospective cohort study , audit , risk stratification , pediatrics , emergency medicine , thrombosis , management , economics , atrial fibrillation
Background Venous thromboembolism ( VTE ) represents a major public health problem in A ustralia and worldwide, contributing to hundreds of thousands of deaths each year. Aim To assess adherence to recommended guidelines in a range of clinical settings. Methods Retrospective, observational study of 955 medical ( M ), surgical ( S ) and orthopaedic ( O ) patient charts of all M , S and O patients admitted during M arch 2011. Patients on warfarin were excluded from the analysis. Appropriate or inappropriate prophylaxis was assessed according to high, medium and low risk stratification. Patient risk stratification for VTE , suitability of prophylaxis given, adverse events and length of stay were recorded. Results Nine hundred and thirteen eligible patients were assessed, 54% male, mean age 57 ± 21 years. Regarding the 372  M patients, 235 (63%) were on appropriate prophylaxis, compared with 84% (273/326) S and 78% (168/215) O patients ( M to S , P < 0.0001; M to O , P = 0.0002; S to O , P = 0.113). High risk prevalence was 56% in M , 9% in S and 12% in O patients ( P < 0.0001). Nine confirmed or possible VTE events occurred (seven M , with five of these on inappropriate prophylaxis). All three bleeding events (one fatal) were in M patients, two of whom had appropriate prophylaxis. Average length of stay was 4.1 ± 5.0, 2.1 ± 3.3 and 2.1 ± 3.8 days ( P < 0.001) for M , S and O patients respectively. Conclusion Better adherence to prophylaxis guidelines is required, especially in M patients where the prevalence of high‐risk VTE is greater.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom